Toll Brothers Inc (TOL) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in its latest quarter and has positive long-term growth potential as per analysts, the technical indicators and trading trends suggest a lack of immediate upside. Additionally, insider selling and negative short-term stock trend projections indicate caution. Holding off on investment for now may be prudent until a clearer entry point emerges.
The MACD histogram is -0.813, below 0, and is negatively contracting, indicating bearish momentum. RSI is at 32.013, in the neutral zone with no clear signal. Moving averages are converging, showing no strong directional trend. The stock is trading near its S1 support level of 132.125, with resistance at 137.229. Short-term stock trend analysis predicts a 100% chance of a -0.89% drop in the next day, -2.48% in the next week, and -11.35% in the next month.

Hedge funds are significantly increasing their buying activity, with a 289.76% increase over the last quarter.
Analysts have raised price targets, with some projecting values as high as $198, citing the company's strong positioning in the luxury home market.
Revenue, net income, and EPS have shown significant YoY growth in Q1 2026, indicating strong financial performance.
Insiders are selling heavily, with a 1144.47% increase in selling activity over the last month.
The broader market is under pressure due to geopolitical tensions and rising oil prices, which could negatively impact the housing market.
Technical indicators and short-term stock trends suggest bearish momentum, with a high probability of further price declines in the near term.
In Q1 2026, Toll Brothers reported a 15.41% YoY increase in revenue to $2.14 billion, an 18.70% YoY increase in net income to $210.93 million, and a 25.14% YoY increase in EPS to $2.19. However, gross margin dropped by 10.15% YoY to 22.3%, indicating some pressure on profitability.
Analysts are generally positive on Toll Brothers, with multiple firms raising price targets recently. UBS has the highest target at $198 with a Buy rating, while Truist initiated coverage with a Buy rating and a $190 target, citing undervaluation and long-term growth potential. However, some analysts remain cautious, with Barclays maintaining an Underweight rating and a lower price target of $116.